Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: FTSE Edges Up As Smith & Nephew And Lloyds Gain

Thu, 20th Feb 2020 08:37

(Alliance News) - The FTSE 100 was hesitantly in the green early Thursday amid ongoing caution surrounding the coronavirus outbreak, though well-received results from Smith & Nephew and Lloyds Bank were helping to lift the index.

The FTSE 100 was up 3.32 points, or 0.1%, at 7,460.34 early Thursday. The mid-cap FTSE 250 index was up 75.95 points, or 0.4%, at 21,926.81. The AIM All-Share index was up 0.3% at 975.71.

The Cboe UK 100 index was up 0.1% at 12,641.25. The Cboe 250 was up 0.4% at 19,756.90, and the Cboe Small Companies flat at 12,482.35.

In mainland Europe, the CAC 40 in Paris and DAX 30 in Frankfurt both were own 0.1% early Thursday.

"European indices have opened on a slightly softer note, backtracking from a big up day. European shares had already been pricing in the extra Chinese stimulus efforts so are looking ahead to the release of accounts of the latest ECB meeting later," said Jasper Lawler at London Capital Group.

China announced it will cut interest rates in a bid to boost the economy, as it battles the economic fallout of the new coronavirus outbreak.

The reduction in the loan prime rate – one of the preferential rates commercial banks impose on their best customers and which serves as a reference for other lending rates - is the latest measure to help companies struggling through the epidemic.

The one-year LPR was lowered to 4.05% from 4.15%, the People's Bank of China said in a statement. The five-year LPR – on which many lenders base their mortgage rates - was also lowered to 4.75% from 4.8%.

The rate reduction comes as Beijing battles to control a virus epidemic that has infected over 74,500 people in the country.

China reported a big drop in new coronavirus cases on Thursday, fuelling hopes the epidemic is nearing its peak. More than 600 new infections were reported in Wuhan, ground zero of the virus, marking the lowest daily tally since late January, and well down from the 1,749 new cases the day before.

In Tokyo on Thursday, the Nikkei 225 index ended up 0.3%. In China, the Shanghai Composite closed up 1.8%, while the Hang Seng index in Hong Kong closed down 0.2%.

At the top of London's FTSE 100 was Smith & Nephew, the stock up 6.0% after the medical technology firm reported an improved rate of underlying revenue growth for 2019.

Revenue for 2019 amounted to USD5.14 billion, up 4.8% on the year before. Underlying revenue growth was 4.4%, a significant improvement on the 2% recorded for 2018.

Pretax profit was slightly lower at USD743 million versus USD781 million the year before, hampered by increases in selling, general & administrative expenses as well as research & development costs.

The medical technology business recorded a trading profit margin of 22.8%.

For 2020, Smith & Nephew expects underlying revenue growth around 3.5% to 4.5%, which equates to a range of 4.0% to 5.0% on a reported basis. The trading profit margin for 2020 should be at or "slightly above" that achieved in 2019.

Lloyds Banking shares were up 3.1% despite the lender taking a hit to 2019 from a hefty payment protection insurance charge.

Net interest income for 2019 amounted to GBP10.18 billion, down from GBP13.40 billion in 2018.

Pretax profit was down 26% to GBP4.39 billion from GBP5.96 billion a year ago, hurt by payment protection insurance provisions of GBP2.45 billion in the year, versus just GBP750 million in 2019.

"The upside to all of this is that at least the PPI saga looks to be finally behind them, with no further provisions made in this quarter, so there's a big silver lining there," said Michael Hewson at CMC Markets.

At the bottom of the FTSE 100 was Imperial Brands, down 4.1% as the tobacco major went ex-dividend, meaning new buyers no longer qualify for the latest payout. GlaxoSmithKline, down 1.5%, also was ex-dividend.

The economic events calendar on Thursday has UK retail sales figures at 0930 GMT, followed by Irish inflation at 1100 GMT and minutes from the European Central Bank's January meeting at midday.

Ahead of the retail sales data, sterling was quoted at USD1.2888 early Thursday, down from USD1.2947 at the London equities close on Wednesday.

"Today's UK data is likely to receive a lot of attention as markets look for indications that the post-election activity pickup is continuing," said Lloyds Bank.

The euro traded at USD1.0788 early Thursday, soft against USD1.0793 late Wednesday. Against the yen, the dollar was quoted at JPY111.67, up from JPY110.93.

Brent oil was trading at USD59.02 a barrel early Thursday, up from USD58.88 late Wednesday.

Gold was quoted at USD1,609.10 an ounce early Thursday, higher than USD1,605.82 on Wednesday.

"Our best assumption is that the [gold] breakout holds and that prices move in the direction of 1650 per oz in fairly short order," said LCG's Lawler.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.